ebook Munafa Stock Market Course + Intraday & FNO calls  

       

NVO announcements Novo Nordisk A/s announcements and dividends declared NYSE

Novo Nordisk A/s Complete list of announcements declared & dividend announcements by Novo Nordisk A/s NVO

Novo Nordisk A/s NVO listed on NYSE and deals in Health Care Major Pharmaceuticals

Announcements and dividends declared by Novo Nordisk A/s NVO

Novo Nordisk Just Took a 0 Million Step Onto Moderna's Turf. Here's What It Means for Both Stocks
On Sept. 16 Novo Nordisk (NYSE: NVO) and Korro Bio (NASDAQ: KRRO) announced that they'd be starting a new drug-development collaboration worth hundreds of millions of dollars, in an area that most would assume to be Moderna's (NASDAQ: MRNA) home territory.
Announcement as on 19 September 2024

Goldman-backed Aragen eyes Rs 12,000 crore as pre-IPO dose; Novo Nordisk keen
Investors including Quadria Capital and Denmark-based pharmaceutical major Novo Nordisk are among those interested in a minority stake and engaged in early discussions, they said. In February, Novo Holdings, the holding company of Novo Nordisk, acquired US
Announcement as on 18 September 2024

Novo Nordisk obesity drug works for kids as young as 6, study finds

Announcement as on 10 September 2024

Novo Nordisk not yet ready to bring in popular obesity, diabetes injectables
Novo Nordisk's launch of weight-loss and diabetes drugs Wegovy and Ozempic in India hinges on resolving supply issues. The company is scaling up production and may consider local fill-finish options. Currently, the injectable forms are not approved in Indi
Announcement as on 06 September 2024

SSUHS signs MoU with Novo Nordisk Foundation
Srimanta Sankaradeva University of Health Sciences and Novo Nordisk Foundation signed an MoU to enhance Assam's health sector. The deal aims to improve nursing education, including an Education Innovation Unit and Simulation Lab. The partnership provides i
Announcement as on 12 August 2024

Announcements by Novo Nordisk A/s first page | Next page | Prev page |

NVO Novo Nordisk A/s current price & indicator signals

Moving Averages for Novo Nordisk A/s

  • 5Day Average: 37.93
  • 12Day Average: 39.24
  • 20Day Average: 41.1
  • 50Day Average: 44.68
  • 100Day Average: 45.51
  • 150Day Average: 43.57
  • 200Day Average: 45.7

NVO Indicators & signals

Indicator MACD (12,26,9)

39.23, 41.42, -1.93
Indicator MACD is in negative zone

Indicator ADX (14)

46.03, 14.78, 40
Indicator ADX is indicating that momentum is weak.
Momentum is towards selling.

Indicator RSI (14)

Current RSI is: 48
Indicator RSI is indicating buying momentum and stock might rise.

Recent prices of NVO Novo Nordisk A/s are as follows: Daily volume is divided by 10 day averaged volume

Date Close Range Change % Volume
02 Fri Oct 2026 37.32 37.17 to 37.65 -0.24% 0.61 times
01 Thu Oct 2026 37.41 37.37 to 38.15 -1.32% 0.55 times
30 Wed Sep 2026 37.91 37.89 to 38.77 -1.04% 1.28 times
29 Tue Sep 2026 38.31 38.05 to 38.38 -1.03% 0.56 times
28 Mon Sep 2026 38.71 38.23 to 38.90 -0.21% 0.68 times
25 Fri Sep 2026 38.79 38.41 to 38.88 0.41% 0.45 times
24 Thu Sep 2026 38.63 37.61 to 38.72 1.21% 0.87 times
23 Wed Sep 2026 38.17 38.16 to 39.14 -3.12% 1.1 times
22 Tue Sep 2026 39.40 39.11 to 39.89 -1.05% 1.45 times
21 Mon Sep 2026 39.82 39.54 to 43.72 -7.91% 2.44 times
18 Fri Sep 2026 43.24 42.78 to 43.54 0.12% 0.62 times
17 Thu Sep 2026 43.19 41.96 to 43.44 3.55% 0.77 times

Videos related to: NVO announcements Novo Nordisk A/s announcements and dividends declared NYSE

Hindi Video Correct Way Of Fundamental Analysis Using EPS And PE - MunafaSutra

Hindi Video What Is Needed To Succeed In Stock Markets

NVO announcements Novo Nordisk A/s announcements and dividends declared NYSE

 

Back to top